货号:A481951
同义名:
dl-Flurbiprofen; Ansaid
Flurbiprofen是一种非甾体抗炎药(NSAIA),具有退热和镇痛活性。 (±)-Flurbiprofen在前列腺癌、家族性腺瘤性息肉病和脑癌模型中抑制肿瘤生长,维持在诱导分化的条件下生长的 hESC 细胞的自我更新和多能性。
HazMat Fee + There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
| Type | HazMat fee for 500 gram (Estimated) |
| Excepted Quantity | USD 0.00 |
| Limited Quantity | USD 15-60 |
| Inaccessible (Haz class 6.1), Domestic | USD 80+ |
| Inaccessible (Haz class 6.1), International | USD 150+ |
| Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
| Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Flurbiprofen is a nonsteroidal anti-inflammatory agent (NSAIA) with antipyretic and analgesic activity. |
| Concentration | Treated Time | Description | References | |
| Rabbit skin | 150 mg | 24 hours | Evaluate the penetration enhancement effect of GER-C14 on Flurbiprofen, results showed GER-C14 had the best penetration promotion effect. | Asian J Pharm Sci. 2022 Jan;17(1):139-152 |
| HCA-7 cells | 11.7 µM | 16 hours | R-flurbiprofen inhibited PGE2 release in HCA-7 cells with an IC50 of 11.7 µM. | Int J Mol Sci. 2016 Dec 30;18(1):68 |
| A-549 cells | 5.6 µM | 16 hours | R-flurbiprofen inhibited PGE2 release in A-549 cells with an IC50 of 5.6 µM. | Int J Mol Sci. 2016 Dec 30;18(1):68 |
| HeLa cells | 5.1 µM | 16 hours | R-flurbiprofen inhibited PGE2 release in HeLa cells with an IC50 of 5.1 µM. | Int J Mol Sci. 2016 Dec 30;18(1):68 |
| B103 murine neuronal cell line | 400 μM or 1 mM | 6 and 9 hours post-infection | Flurbiprofen in combination with the caspase inhibitor Z-VAD-fmk drastically reduced HSV-1-induced Aβ42 oligomer production. | Transl Psychiatry. 2023 Mar 10;13(1):86 |
| Caco-2 cells | 0, 0.5, 2.5, 5, 25, 50 µg/mL (corresponds to 0, 2, 10.2, 20.5, 102.3, 204.7 µM) | 24 h or 48 h | To investigate the effect of flurbiprofen on ACE2 mRNA and protein expression. Results showed flurbiprofen did not alter ACE2 mRNA expression but slightly increased ACE2 protein expression. | Int J Mol Sci. 2022 Jan 19;23(3):1049 |
| C6 glial cells | 200 µM | 4 hours | To assess the effect of FP-loaded dendrimeric delivery systems on γ-secretase enzyme activity. Results showed that FP and FP-dendrimer complexes significantly reduced γ-secretase activity. | Int J Mol Sci. 2018 Oct 18;19(10):3224 |
| bEnd.3 cells | 25 to 400 µM | 24 and 48 hours | To evaluate the cytotoxicity and biocompatibility of FP-loaded dendrimeric delivery systems. Results showed cell viability exceeding 70% at concentrations up to 400 µM, indicating these delivery systems were non-toxic to these cells. | Int J Mol Sci. 2018 Oct 18;19(10):3224 |
| Administration | Dosage | Frequency | Description | References | ||
| Japanese white rabbits | Transdermal delivery model | Transdermal administration | 208.8 mg | Single dose, 48 hours duration | Evaluate the pharmacokinetic impact of GER-C14 on Flurbiprofen, results showed GER-C14 significantly increased Cmax and AUC0-48. | Asian J Pharm Sci. 2022 Jan;17(1):139-152 |
| Sprague-Dawley rats | Collagenase II-induced knee osteoarthritis model | Intra-articular injection | 0.5 mg/time | Every 72 hours for 7 times | To evaluate the therapeutic effects of flurbiprofen thermogel in a knee osteoarthritis model, showing significant reduction in pain and inflammatory response. | Drug Deliv. 2020 Dec;27(1):1034-1043 |
| Japanese white rabbits | Transdermal delivery model | Transdermal administration | 208.8 mg FP | Single dose, 48 hours duration | To evaluate the transdermal enhancement effect of GER-C14 in vivo. Results showed that the GER-C14 group had the highest AUC0–48, indicating the strongest transdermal enhancement effect. | Asian J Pharm Sci. 2022 Jan;17(1):139-152 |
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT02191358 | - | Completed | - | United States, California ... 展开 >> Dr. Michael Dao Garden Grove, California, United States, 92844 United States, Colorado Kaiser Permanente Colorado Denver, Colorado, United States, 80011 United States, Kentucky Gill Heart Institute Lexington, Kentucky, United States, 40508 United States, Maryland IRC Clinics Towson, Maryland, United States, 21204 United States, Massachusetts Internal Medicine & Cardiology Associates Fall River, Massachusetts, United States, 02720 Prima CARE Fall River, Massachusetts, United States, 02720 United States, Virginia Carilion Clinic Christiansburg, Virginia, United States, 24073 收起 << | |
| NCT03520907 | Postoperative Pain ... 展开 >> Inguinal Hernia Unilateral Children, Only 收起 << | Not Applicable | Recruiting | April 2019 | Japan ... 展开 >> Ibaraki Children's Hospital Recruiting Mito, Ibaraki, Japan, 311-4145 Contact: Kazuhiko Okuyama, MD 81-29-254-1151 okuokukk@gmail.com Principal Investigator: Yuki Takeda, MD Sub-Investigator: Iwao Sukegawa, MD 收起 << |
| NCT02784041 | Osteoarthritis,Knee | Not Applicable | Unknown | December 2018 | China ... 展开 >> Peking Union Medical College Hospital Beijing, China, 100730 收起 << |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
4.09mL 0.82mL 0.41mL |
20.47mL 4.09mL 2.05mL |
40.94mL 8.19mL 4.09mL |
|
| CAS号 | 5104-49-4 |
| 分子式 | C15H13FO2 |
| 分子量 | 244.26 |
| SMILES Code | O=C(O)C(C)C1=CC=C(C2=CC=CC=C2)C(F)=C1 |
| MDL No. | MFCD00079303 |
| 别名 | dl-Flurbiprofen; Ansaid; Flurbiprofen, Ansaid, Froben, Cebutid, Antadys; (±)-Flurbiprofen |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, sealed in dry, room temperature |
| 溶解方案 |
DMSO: 105 mg/mL(429.87 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1